DefEYE Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $12M

  • Investors
  • 3

DefEYE General Information

Description

Developer of ophthalmic-biologic technology intended for ocular surface repair and surgery. The company's platform offers a portfolio of decellularized human amniotic and placental basement-membrane products, tri-layer and single-layer architectures with preserved natural extracellular matrix structure, multiple sizes and shapes, room-temperature shelf stability, and compatibility with both in-office and surgical applications, enabling eye-care practitioners and healthcare institutions to access regenerative biologic tools for managing complex ocular surface disease, pterygium repair, and other surgical interventions.

Contact Information

Website
www.defeye.com
Formerly Known As
Verséa Ophthalmics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • FL
  • United States
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • FL
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DefEYE Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 31-Oct-2025 $12M Completed Generating Revenue
To view DefEYE’s complete valuation and funding history, request access »

DefEYE Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series Seed-2
Series Seed-1
To view DefEYE’s complete cap table history, request access »

DefEYE Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BRIDGE Angel Investors Angel Group Minority
Celularity Corporation Minority
ExSight Ventures Venture Capital Minority
To view DefEYE’s complete investors history, request access »

DefEYE FAQs

  • When was DefEYE founded?

    DefEYE was founded in 2022.

  • Where is DefEYE headquartered?

    DefEYE is headquartered in FL.

  • What industry is DefEYE in?

    DefEYE’s primary industry is Surgical Devices.

  • Is DefEYE a private or public company?

    DefEYE is a Private company.

  • What is the current valuation of DefEYE?

    The current valuation of DefEYE is .

  • What is DefEYE’s current revenue?

    The current revenue for DefEYE is .

  • How much funding has DefEYE raised over time?

    DefEYE has raised $12M.

  • Who are DefEYE’s investors?

    BRIDGE Angel Investors, Celularity, and ExSight Ventures have invested in DefEYE.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process